| Issue | Title | |
| Vol 2019, No 1 (2019) | Codiak Biosciences’ Exosome Therapeutics Attracts Jazz Pharmaceuticals | Abstract pdf html |
| Michelle Liu | ||
| Vol 2023, No 6 (2023) | Coherus Biosciences to Buy Surface Oncology for US$65 M | Abstract pdf html |
| Lucy Haggerty | ||
| Vol 2021, No 2 (2021) | Coherus Catapults into Immuno-oncology Field with US$1.8 B Junshi Alliance | Abstract pdf html |
| Michelle Liu | ||
| Vol 2002, No 24 (2002) | Cohesion and Zycos in PEG drug delivery collaboration | Abstract pdf |
| Business Review Editor | ||
| Vol 2024, No 8 (2024) | Collegium to Acquire Ironshore Therapeutics for US$525 M | Abstract pdf html |
| Ayush Saxena | ||
| Vol 2005, No 65 (2005) | CombinatoRx and Angiotech Collaborate in Systems Biology | Abstract pdf |
| Business Review Editor | ||
| Vol 2009, No 8 (2009) | CombinatoRx and Clinical Data Collaborate on Adenosine Agonist for Cancer | Abstract |
| Taskin Ahmed | ||
| Vol 2006, No 69 (2006) | CombinatoRx and Fovea in Alliance to Treat Ophthalmic Disease | Abstract pdf |
| Business Review Editor | ||
| Vol 2009, No 7 (2009) | CombinatoRx and Neuromed Sign Merger Agreement | Abstract |
| Taskin Ahmed | ||
| Vol 2009, No 5 (2009) | CombinatoRx's Oncology Collaboration with Novartis | Abstract |
| Taskin Ahmed | ||
| Vol 2016, No 12 (2016) | Committed to Amyloid Research, Lilly Expands its Collaboration with AstraZeneca | Abstract pdf html |
| Natasha Berry & Jawala Prasad | ||
| Vol 2007, No 87 (2007) | Communicating Health | Abstract html |
| Fintan Walton | ||
| Vol 2005, No 66 (2005) | Communication, Trust and the Deal | Abstract html |
| Fintan Walton | ||
| Vol 2005, No 59 (2005) | Competition Forces Organon and J&J to Terminate Co-Promotion of Risperdal® | Abstract pdf |
| Business Review Editor | ||
| Vol 2008, No 94 (2008) | Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector: a review of a recently published report | Abstract pdf |
| Business Review Editor | ||
| Vol 2013, No 5 (2013) | Concert Pharmaceuticals Snags Celgene as a Partner for its DCE Platform® | Abstract |
| Heather Cartwright | ||
| Vol 2006, No 77 (2006) | Conference Report: Drug Discovery Partnerships and Outsourcing | Abstract pdf |
| Business Review Editor | ||
| Vol 2012, No 6 (2012) | Consolidation and Differentiation: Key Drivers of Change in the Global Pharmaceutical Manufacturing Industry | Abstract |
| Cynthia Tso, Jansen Jacob | ||
| Vol 2012, No 2 (2012) | Constellation and Genentech Form Broad Epigenetics Collaboration with Buyout Option | Abstract |
| Heather Cartwright | ||
| Vol 2006, No 76 (2006) | Controlling Value in Deals | Abstract html |
| Fintan Walton | ||
| Vol 2009, No 10 (2009) | Cool Hats | Abstract jpg |
| Clive Goddard | ||
| Vol 2003, No 42 (2003) | Corgentech Clinches Bristol-Myers Squibb Alliance | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 56 (2005) | Corixa Hands Over Bexxar® Rights to GSK | Abstract |
| Business Review Editor | ||
| Vol 2013, No 9 (2013) | Cornerstone Therapeutics Accepts Sweetened Buyout Offer from Majority Shareholder Chiesi | Abstract |
| Heather Cartwright | ||
| Vol 2009, No 5 (2009) | Cornerstone's Strategic Transaction with Chiesi | Abstract |
| Taskin Ahmed | ||
| Vol 2022, No 8 (2022) | Could Biopharma M&A Activity be on the Rise? | Abstract pdf html |
| Lucy Haggerty & Taskin Ahmed | ||
| Vol 2009, No 3 (2009) | Could J&J Trip up the Merck and Schering-Plough Deal? | Abstract |
| Taskin Ahmed | ||
| Vol 2005, No 64 (2005) | Covance Acquires Clinical Services Facility from West Pharmaceutical | Abstract pdf |
| Business Review Editor | ||
| Vol 2010, No 9 (2010) | Covance Becomes Sanofi-aventis’ R&D Partner | Abstract |
| Heather Cartwright | ||
| Vol 2009, No 5 (2009) | Covidien Acquires VNUS Medical Technologies for US$440 M | Abstract |
| Taskin Ahmed | ||
| Vol 2020, No 12 (2020) | Covis Group Acquires AMAG Pharmaceuticals for US$498 M | Abstract pdf html |
| Sasha Yachu & Michelle Liu | ||
| Vol 2006, No 67 (2006) | Crucell and Berna Biotech to Create Large Independent Vaccine Company | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 28 (2002) | Crucell and NatImmune Sign Licensing Agreement | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 74 (2006) | CrystaX Pharmaceuticals SL | Abstract |
| Business Review Editor | ||
| Vol 2020, No 7 (2020) | CSL Behring Licenses Phase III Haemophilia B Gene Therapy Candidate from uniQure | Abstract pdf html |
| Sasha Yachu & Michelle Liu | ||
| Vol 2004, No 44 (2004) | CSL Combines with Aventis to Create ZLB Behring | Abstract pdf |
| Business Review Editor | ||
| Vol 2021, No 12 (2021) | CSL Hands Over US$11.7 B to Acquire Vifor Pharma | Abstract pdf html |
| Sasha Yachu | ||
| Vol 2008, No 99 (2008) | CSL Seeks to Solidfy its Position by Acquiring Talecris | Abstract pdf html |
| Taskin Ahmed | ||
| Vol 2013, No 3 (2013) | Cubist Gains Option to Acquire Adynxx with Diversification in Mind | Abstract |
| Heather Cartwright | ||
| Vol 2011, No 11 (2011) | Cubist Looks to Opioid Receptor Antagonists with Potential US$415 M Adolor Takeover | Abstract |
| Heather Cartwright | ||
| Vol 2004, No 50 (2004) | CuraGen Licenses Seattle Genetics’ ADC Technology | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 49 (2004) | CuraGen Licenses TopoTarget’s HDAC Inhibitor | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 59 (2005) | Curis and Genentech Join Forces Again | Abstract pdf |
| Business Review Editor | ||
| Vol 2022, No 2 (2022) | Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform | Abstract pdf html |
| Ayush Saxena & Lucy Haggerty | ||
| Vol 2008, No 100 (2008) | CV Therapeutics Aims High Through its Agreement with Menarini | Abstract pdf html |
| Sally Mardikian PhD | ||
| Vol 2018, No 7 (2018) | CVC Capital Acquires Controlling Stake in Recordati | Abstract pdf html |
| Jasmine Kalsi | ||
| Vol 2005, No 64 (2005) | Cyto Pulse Collaborates with US Army | Abstract pdf |
| Business Review Editor | ||
| Vol 2007, No 80 (2007) | Cytokinetics and Amgen Enter into Collaboration for Heart Failure | Abstract pdf |
| Business Review Editor | ||
| Vol 2013, No 7 (2013) | Cytokinetics Gains Astellas as Partner in Field of Skeletal Muscle Activation | Abstract |
| Heather Cartwright | ||
| Vol 2008, No 99 (2008) | Cytos Signs Vaccines Deal with Pfizer | Abstract pdf html |
| Taskin Ahmed | ||
| Vol 2007, No 82 (2007) | Cytyc - A Positive Outlook | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 61 (2005) | Dacogen (decitabine) | Abstract pdf |
| Business Review Editor | ||
| Vol 2012, No 3 (2012) | Daiichi Sankyo and GSK to Establish Vaccines Joint Venture in Japan | Abstract |
| Heather Cartwright | ||
| Vol 2008, No 96 (2008) | Daiichi Sankyo Boosts Oncology Portfolio with Acquisition of Biotech, U3 Pharma | Abstract pdf html |
| Helen Scrutton | ||
| Vol 2008, No 97 (2008) | Daiichi Sankyo Diversifies into Generics through Major Investment in Indian Giant | Abstract pdf html |
| Sally Mardikian PhD | ||
| Vol 2011, No 3 (2011) | Daiichi Sankyo Targets US Oncology Market with US$935 M Plexxikon Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2005, No 55 (2005) | Dainippon and Sumitomo Follow in the Footsteps of Yamanouchi and Fujisawa | Abstract pdf |
| Business Review Editor | ||
| Vol 2013, No 4 (2013) | Dainippon Sumitomo Licenses Japanese Rights to Two Redox-Directed Drugs from Edison Pharmaceuticals | Abstract |
| Heather Cartwright | ||
| Vol 2012, No 3 (2012) | Dainippon Sumitomo Pharma Expands its Oncology Presence with Boston Biomedical Acquisition | Abstract |
| Heather Cartwright | ||
| Vol 2021, No 7 (2021) | Danaher Continues Life Sciences Business Expansion with US$9.6 B Aldevron Acquisition | Abstract pdf html |
| Debadrita Paul | ||
| Vol 2005, No 58 (2005) | De Novo Pharmaceuticals Ltd | Abstract |
| Business Review Editor | ||
| Vol 2007, No 83 (2007) | Deal box | Details jpg |
| Business Review Editor | ||
| Vol 2005, No 56 (2005) | Deal Making in the Biopharmaceutical Sector | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 31 (2002) | Deal Making in the Drug Delivery Sector | Abstract |
| Business Review Editor | ||
| Vol 2006, No 68 (2006) | Deal Making in the New Healthcare Landscape | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 25 (2002) | Deal Making in the Pharmaceutical Fine Chemical Industry | Abstract |
| Business Review Editor | ||
| Vol 2006, No 74 (2006) | Deal Making Review: 2000-2005, with Projections for 2006 | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 72 (2006) | Deal Making Spotlights on Big Pharma | Abstract pdf |
| Business Review Editor | ||
| Vol 2009, No 9 (2009) | Deal Making Trends in Oncology | Abstract |
| Josef Walker | ||
| Vol 2005, No 59 (2005) | Deal Making Trends of Top Pharma Companies | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 73 (2006) | Deal termination | Details jpg |
| Business Review Editor | ||
| Vol 2019, No 12 (2019) | Deal Trends in Gene Therapy | Abstract pdf |
| Michelle Liu & Taskin Ahmed | ||
| Vol 2019, No 1 (2019) | Deal Trends in Immuno-Oncology | Abstract pdf |
| Natasha Piper, Heather Cartwright & Taskin Ahmed | ||
| Vol 2006, No 69 (2006) | Dealing with Litigation | Abstract |
| Business Review Editor | ||
| Vol 2010, No 1 (2010) | Dealing with the Wolf | Abstract jpg |
| Clive Goddard | ||
| Vol 2012, No 1 (2012) | Decision Maker | Abstract jpg |
| Clive Goddard | ||
| Vol 2018, No 12 (2018) | Decline in Big Pharma Deal Activity Mirrors Industry-wide Slowdown in Dealmaking | Abstract pdf |
| Jawala Prasad & Jasmine Kalsi | ||
| Vol 2002, No 25 (2002) | Degussa AG divests pharmaceutical interests | Abstract pdf |
| Business Review Editor | ||
| Vol 2007, No 88 (2007) | Delivering Success from Seed Capital Investment | Abstract pdf |
| Business Review Editor | ||
| Vol 2004, No 51 (2004) | Deltanoid’s and Abbott’s Renal Partnership | Abstract |
| Business Review Editor | ||
| Vol 2018, No 6 (2018) | Denali Therapeutics Exercises Option to Acquire F-Star Gamma | Abstract pdf html |
| Natasha Piper | ||
| Vol 2002, No 28 (2002) | Dendreon and Genentech to Collaborate on Trp-p8 Gene Platform | Abstract pdf |
| Business Review Editor | ||
| Vol 2003, No 34 (2003) | Dendreon to Acquire Corvas | Abstract pdf |
| Business Review Editor | ||
| Vol 2003, No 37 (2003) | deVGen NV | Abstract pdf |
| Business Review Editor | ||
| Vol 2002, No 28 (2002) | Diacrin Licenses Transplantation Technology to Terumo | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 69 (2006) | Diagnose This | Abstract html |
| Fintan Walton | ||
| Vol 2006, No 74 (2006) | Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 72 (2006) | Diquafosol | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 69 (2006) | Divestments and Acquisitions: A Changing Landscape | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 60 (2005) | Dividing Opinion: Shire's Move to Purchase TKT | Abstract pdf |
| Business Review Editor | ||
| Vol 2005, No 61 (2005) | Don't Make Your Drug Deals Poison Pills | Details html |
| Fintan Walton | ||
| Vol 2007, No 86 (2007) | Dong Wha Goes Global with P&G | Abstract pdf |
| Business Review Editor | ||
| Vol 2008, No 94 (2008) | Dr. Reddy's Acquisition Sweeps through Europe | Abstract pdf html |
| Sally Mardikian PhD | ||
| Vol 2006, No 69 (2006) | Dr. Reddy’s Acquires betapharm to Expand European Operations | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 76 (2006) | Drastic Measures: Ligand Sells All its Marketed Products | Abstract pdf |
| Business Review Editor | ||
| Vol 2003, No 33 (2003) | Drug Delivery Alliance Development Process | Abstract |
| Business Review Editor | ||
| Vol 2002, No 24 (2002) | Drug Royalty Companies | Abstract |
| Business Review Editor | ||
| Vol 2007, No 79 (2007) | Drug Withdrawals: Pfizer the Latest Victim | Abstract |
| Business Review Editor | ||
| Vol 2002, No 28 (2002) | DSM to Acquire Roche’s Vitamins and Fine Chemicals Division | Abstract pdf |
| Business Review Editor | ||
| Vol 2006, No 74 (2006) | Due Diligence | Details jpg |
| Business Review Editor | ||
| 901 - 1000 of 2623 Items | << < 5 6 7 8 9 10 11 12 13 14 > >> | |